Having a large clinical trial portfolio means giving patients treatment options often not available anywhere else, and years before they become the standard of care. To learn more about Karmanos Cancer Institute clinical trials or to see if a trial is right for you, please call
1-800-KARMANOS (1-800-527-6266)
or request an appointment below
Back to Results
2018-091:Does High-Intensity Functional Training Improve Patient Movement and Quality of Life? A Pilot Study of Cross Training in Cancer Survivors and Caregivers.
Cancer Categories
Breast,Gastrointestinal (GI),Genitourinary (GU),Gynecologic,Hematologic (Blood Cancers),Lung
Karmanos Trial ID
2018-091
NCT ID
NCT03750981
Age Group
Adult
Scope
Local
Phase
Questions, please contact us
N/A
Principal Investigator
Beebe-Dimmer, Jennifer
Objective:
Primary:
Aim I: To estimate a) enrollment rates among those who respond to notices about the study and b) adherence to the program among those who enroll. Further, we will c) describe reported barriers to participation among respondents who do not ultimately enroll.
Aim II: In preparation for a definitive study, to estimate measures of functional performance and variability in functional performance among adult cancer survivors within 48 months of diagnosis enrolled in a high-intensity functional training program (CrossFit) at baseline at regular intervals during the study and at the conclusion of the program.
Aim III: To estimate self-reported health-related quality of life (HRQOL) and variability using the FACT questionnaire at baseline, at regular intervals throughout the pilot study and again at the end of the program.
Aim IV: To estimate changes in weight, body fat percentage, visceral fat, body mass index, resting metabolism and skeletal muscle from baseline at the end of the program.
Aim V: To assess qualitatively (a) motivation to exercise, (b) barriers to exercise, (c) expectations of the intervention, (d) emotional responses to exercise, and (e) satisfaction with the program, starting at baseline and continuing at regular intervals throughout the pilot study until the end of the program.
Request an Appointment
Refer a Patient
NCI Dictionary of Cancer Terms
KCI Clinical Trials App
Eligibility
Locations
Applicable Disease Site
Therapies | Drugs | Devices
Eligibility
Eligibility
Inclusion Criteria:
Aged 18 years or older at time of program recruitment
Diagnosed with an invasive cancer
Cleared from their physician to participate in the program (We assume that most patients will have completed treatment, however if a patient is currently under treatment, this should be their oncologist. If the patient is not currently undergoing treatment, this could be primary care physician or oncologist).
Locations
Locations
Karmanos Cancer Institute - Detroit Headquarters
4100 John R
Detroit, MI 48201
Get Directions
Phone:
1-800-527-6266
Applicable Disease Site
Applicable Disease Site
Breast; Colon; Hodgkin Lymphoma; Kidney; Lung; Non-Hodgkin Lymphoma; Other Female Genital; Prostate; Rectum
Therapies, Drugs, Devices
Therapies | Drugs | Devices
Loading...